Jianwei Ge

No.160 Pujian Road
Pudong, 200127, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

NTAN1 Promotes Glioblastoma Malignant Progression and Is a Novel Prognostic Factor of Poor Prognosis.

NTAN1 Promotes Glioblastoma Malignant Progression and Is a Novel Prognostic Factor of Poor Prognosis.

Journal: Biomedicines
Published: July 15, 2026

Glioblastoma with loss of H3K27me3 and EGFR exon 20 insertion: report of a case

Glioblastoma with loss of H3K27me3 and EGFR exon 20 insertion: report of a case

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: April 09, 2026

Chemotherapeutic drug-triggered AEP-cleaved G3BP1 orchestrates stress granules/nucleoli/mitochondria in osteosarcoma.

Chemotherapeutic drug-triggered AEP-cleaved G3BP1 orchestrates stress granules/nucleoli/mitochondria in osteosarcoma.

Journal: Bone research
Published: December 03, 2024

Generation and banking of patient-derived glioblastoma organoid and its application in cancer neuroscience.

Generation and banking of patient-derived glioblastoma organoid and its application in cancer neuroscience.

Journal: American journal of cancer research
Published: May 31, 2024

A Transcription Factor ZNF384, Regulated by LINC00265, Activates the Expression of IFI30 to Stimulate Malignant Progression in Glioma.

A Transcription Factor ZNF384, Regulated by LINC00265, Activates the Expression of IFI30 to Stimulate Malignant Progression in Glioma.

Journal: ACS chemical neuroscience
Published: December 23, 2023

AEP-cleaved DDX3X induces alternative RNA splicing events to mediate cancer cell adaptation in harsh microenvironments.

AEP-cleaved DDX3X induces alternative RNA splicing events to mediate cancer cell adaptation in harsh microenvironments.

Journal: The Journal of clinical investigation
Published: June 27, 2023

Circ_0000189 Promotes the Malignancy of Glioma Cells via Regulating miR-192-5p-ZEB2 Axis.

Circ_0000189 Promotes the Malignancy of Glioma Cells via Regulating miR-192-5p-ZEB2 Axis.

Journal: Oxidative medicine and cellular longevity
Published: February 22, 2022

TFCP2, a binding protein of ATF3, promotes the progression of glioma by activating the synthesis of serine.

TFCP2, a binding protein of ATF3, promotes the progression of glioma by activating the synthesis of serine.

Journal: Experimental cell research
Published: January 29, 2022

LHX9, a p53-binding protein, inhibits the progression of glioma by suppressing glycolysis.

LHX9, a p53-binding protein, inhibits the progression of glioma by suppressing glycolysis.

Journal: Aging
Published: November 24, 2020

Simplified perfusion fraction from diffusion-weighted imaging in preoperative prediction of IDH1 mutation in WHO grade II-III gliomas: comparison with dynamic contrast-enhanced and intravoxel incoherent motion MRI.

Simplified perfusion fraction from diffusion-weighted imaging in preoperative prediction of IDH1 mutation in WHO grade II-III gliomas: comparison with dynamic contrast-enhanced and intravoxel incoherent motion MRI.

Journal: Radiology and oncology
Published: March 23, 2020

SOX9-activated PXN-AS1 promotes the tumorigenesis of glioblastoma by EZH2-mediated methylation of DKK1.

SOX9-activated PXN-AS1 promotes the tumorigenesis of glioblastoma by EZH2-mediated methylation of DKK1.

Journal: Journal of cellular and molecular medicine
Published: December 11, 2019

Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression.

Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression.

Journal: Molecular therapy. Nucleic acids
Published: January 24, 2019
Showing 1-12 of 33

Last Updated: 09/26/2026